Geron | GERN - Current Liabilities


Geron reported $70.33M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Amgen USD 25.5B 547M Jun/2026
Bio Techne USD 153.28M 12.85M Mar/2026
Cassava Sciences USD 40.11M 3.72M Mar/2026
Cytokinetics USD 199.18M 3.27M Mar/2026
Exelixis USD 370.98M 34.67M Mar/2026
Genmab DKK 1.43B 686M Dec/2025
Geron USD 70.33M 3.24M Jun/2026
Gilead Sciences USD 11.02B 1.54B Jun/2026
Incyte USD 1.31B 177.55M Jun/2026
MacroGenics USD 95.94M 52.82M Mar/2026
Novartis USD 31.75B 374M Jun/2026
Novavax USD 342.46M 117.49M Mar/2026